ArticleStem cell research & therapy2018

TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21-IL-4 pathway in lung adenocarcinoma.

Shuangtao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.